Skip to main content

Table 2 Laboratory investigations during 12 months of follow-up

From: Role of transient elastography in the prediction of de novo recurrence of hepatocellular carcinoma after radiofrequency ablation: single-center Egyptian study

 

Base line

1 month

3 months

6 months

12 months

F

P

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Serum albumin (g/dl)

3.88

0.39

3.68

.34

3.59

0.37

3.49

0.46

3.33

0.55

23.21

<0.001

Total bilirubin (mg/dl)

1.14

0.41

1.17

0.47

1.21

0.53

1.30

0.62

1.42

0.78

320.90

<0.001

INR

1.11

0.12

1.16

0.14

1.20

0.14

1.64

0.91

1.26

0.19

1.25

0.29

ALT (u/l)

43.37

14.18

47.87

14.55

44.23

20.73

45.10

20.08

44.23

20.73

1.52

0.20

AST (u/l)

53.73

18.41

56.43

17.87

56.43

17.87

51.87

11.14

52.80

10.65

1.76

0.14

TLC (103/mL)

5.53

2.36

5.17

2.14

5.04

1.92

5.18

2.18

4.84

1.92

1.71

0.15

HB (g/dl)

11.95

1.33

11.75

1.30

11.46

1.13

11.27

1.22

11.17

1.27

13.15

<0.001

Platelets (103/mL)

147830

51700

143830

47380

139730

50330

135800

49750

128730

50.00

7.72

<0.001

BUN (mg/dl)

16.07

6.93

16.83

7.29

17.87

7.61

15.63

5.77

18.73

7.39

1.68

0.16

CR (mg/dl)

0.92

0.19

0.97

0.20

0.99

0.24

1.00

0.26

1.08

0.33

4.004

0.004

NA (meq/l)

136.67

2.09

136.40

2.46

135.50

3.15

134.77

3.45

133.83

5.75

6.33

<0.001

k (meq/l)

4.11

.32

4.04

.31

3.85b

.27

3.86

.35

3.77

0.44

8.75

<0.001

*AFP (ng/dl)

42.00

54.00

8.50

6.00

6.50

6.00

6.30

5.00

6.05

59.00

51.64

<0.001

  1. *Median and IQR